Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Advances in Respiratory Medicine
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Author statement Editorial Policy and Information for Authors Reviewers 2020

open access

Vol 77, No 5 (2009)
Case report
Published online: 2009-08-12
Submitted: 2013-02-22
View PDF Download PDF file
Get Citation

Resolvement of respiratory failure and polycythemia after CPAP treatment in a middle-aged male with severe obstructive sleep apnea

Robert Pływaczewski, Damian Korzybski, Barbara Kazanecka, Luiza Jonczak, Dorota Górecka, Paweł Śliwiński
Pneumonol Alergol Pol 2009;77(5):479-483.

open access

Vol 77, No 5 (2009)
CASE REPORTS
Published online: 2009-08-12
Submitted: 2013-02-22

Abstract

We present the case of a 52 year-old obese (BMI = 46.2 kg/m2) man with severe obstructive sleep apnea (RDI of 60). Before CPAP treatment was applied, the patient was diagnosed with complete respiratory failure and polycythemia. During effective autoCPAP treatment (after 10 days AHI was 5.5 at 10 mbar pressure) we observed normalization of arterial blood gases (PaCO2 of borderline value). After one month’s treatment with autoCPAP at home, we found normalization of blood morphology parameters and PaCO2 had returned to normal, and the patient was properly oxygenated. The patient lost 22 kg during therapy (9 kg in hospital, and 13 kg at home) which resulted in the spirometric measurements returning to their normal value.

Abstract

We present the case of a 52 year-old obese (BMI = 46.2 kg/m2) man with severe obstructive sleep apnea (RDI of 60). Before CPAP treatment was applied, the patient was diagnosed with complete respiratory failure and polycythemia. During effective autoCPAP treatment (after 10 days AHI was 5.5 at 10 mbar pressure) we observed normalization of arterial blood gases (PaCO2 of borderline value). After one month’s treatment with autoCPAP at home, we found normalization of blood morphology parameters and PaCO2 had returned to normal, and the patient was properly oxygenated. The patient lost 22 kg during therapy (9 kg in hospital, and 13 kg at home) which resulted in the spirometric measurements returning to their normal value.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

obstructive sleep apnea; respiratory failure; polycythemia; CPAP

About this article
Title

Resolvement of respiratory failure and polycythemia after CPAP treatment in a middle-aged male with severe obstructive sleep apnea

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 5 (2009)

Article type

Case report

Pages

479-483

Published online

2009-08-12

Bibliographic record

Pneumonol Alergol Pol 2009;77(5):479-483.

Keywords

obstructive sleep apnea
respiratory failure
polycythemia
CPAP

Authors

Robert Pływaczewski
Damian Korzybski
Barbara Kazanecka
Luiza Jonczak
Dorota Górecka
Paweł Śliwiński

References (15)
  1. Krieger J, Sforza E, Apprill M, et al. Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest. 1989; 96(4): 729–737.
    PubMed
  2. Chaouat A, Weitzenblum E, Krieger J, et al. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med. 1995; 151(1): 82–86.
    CrossRefPubMed
  3. Verin E, Tardif C, Pasquis P. Prevalence of daytime hypercapnia or hypoxia in patients with OSAS and normal lung function. Respir Med. 2001; 95(8): 693–696.
    CrossRefPubMed
  4. Kawata N, Tatsumi K, Terada J, et al. Daytime hypercapnia in obstructive sleep apnea syndrome. Chest. 2007; 132(6): 1832–1838.
    CrossRefPubMed
  5. Banerjee D, Yee BJ, Piper AJ, et al. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest. 2007; 131(6): 1678–1684.
    CrossRefPubMed
  6. Resta O, Foschino Barbaro MP, Bonfitto P, et al. Hypercapnia in obstructive sleep apnoea syndrome. Neth J Med. 2000; 56(6): 215–222.
    PubMed
  7. Laaban JP, Chailleux E. Daytime hypercapnia in adult patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest. 2005; 127(3): 710–715.
    CrossRefPubMed
  8. Brzecka A, et al. Hipoksemia w czasie stosowania ciągłego ciśnienia dodatniego w drogach oddechowych (CPAP) u chorych z zespołem obturacyjnego bezdechu śródsennego łistniejącą przewlekłą hiperkapnią. Pneumonol Alergol Pol. 2002; 70: 398–402.
  9. Fanfulla F, Grassi M, Taurino AE, et al. The relationship of daytime hypoxemia and nocturnal hypoxia in obstructive sleep apnea syndrome. Sleep. 2008; 31(2): 249–255.
    PubMed
  10. Carlson JT, Hedner J, Fagerberg B, et al. Secondary polycythaemia associated with nocturnal apnoea--a relationship not mediated by erythropoietin? J Intern Med. 1992; 231(4): 381–387.
    PubMed
  11. Zgierska A, Koziej M, Pływaczewski R. Skrajna poliglobulia u chorych na obturacyjny bezdech senny. Pol Arch Med Wewn. 1997; 97: 458–464.
  12. Hoffstein V, Herridge M, Mateika S, et al. Hematocrit levels in sleep apnea. Chest. 1994; 106(3): 787–791.
    PubMed
  13. Krieger J, Sforza E, Delanoe C, et al. Decrease in haematocrit with continuous positive airway pressure treatment in obstructive sleep apnoea patients. Eur Respir J. 1992; 5(2): 228–233.
    PubMed
  14. Krieger J, Sforza E, Barthelmebs M, et al. Overnight decrease in hematocrit after nasal CPAP treatment in patients with OSA. Chest. 1990; 97(3): 729–730.
    PubMed
  15. Choi JB, Loredo JS, Norman D, et al. Does obstructive sleep apnea increase hematocrit? Sleep Breath. 2006; 10(3): 155–160.
    CrossRefPubMed

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl